{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:22:59Z","timestamp":1777879379213,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["YCX2025-01-42"],"award-info":[{"award-number":["YCX2025-01-42"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYYZZ25-17"],"award-info":[{"award-number":["CYYZZ25-17"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204308"],"award-info":[{"award-number":["82204308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC2105"],"award-info":[{"award-number":["2024NSFSC2105"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024qnGzn11"],"award-info":[{"award-number":["2024qnGzn11"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114941","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:38:10Z","timestamp":1764117490000},"page":"114941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Probing in vivo drug release of macrophage-targeting liposomes"],"prefix":"10.1016","volume":"218","author":[{"given":"Hongling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangxue","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-848X","authenticated-orcid":false,"given":"Yaxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpb.2025.114941_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s10876-025-02836-9","article-title":"Application of liposome-based drug delivery systems in tumor treatment","volume":"36","author":"Sun","year":"2025","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.ejpb.2025.114941_b0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jconrel.2023.12.049","article-title":"Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes","volume":"366","author":"Kim","year":"2024","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.ejpb.2025.114941_b0015","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1039\/D4BM00478G","article-title":"Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes","volume":"12","author":"Paolino","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2025.114941_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent advances and clinical translation of liposomal delivery systems in cancer therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114941_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113731","article-title":"Cancer nanomedicine from a clinician-scientist perspective: Lessons and prospects","volume":"382","author":"Gabizon","year":"2025","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114941_b0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/08982104.2024.2325963","article-title":"Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy","volume":"34","author":"Hajimolaali","year":"2024","journal-title":"J. Liposome Res."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114941_b0035","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2025.114941_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for in flammatory diseases","volume":"165\u2013166","author":"He","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114941_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114941_b0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jconrel.2020.09.046","article-title":"Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles","volume":"328","author":"Biancacci","year":"2020","journal-title":"J. Control. Release"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2025.114941_b0055","first-page":"136","article-title":"Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes","volume":"965","author":"Storm","year":"1988","journal-title":"BBA"},{"key":"10.1016\/j.ejpb.2025.114941_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9692","article-title":"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug","volume":"6","author":"Miller","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114941_b0065","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1021\/acsnano.1c11578","article-title":"Macrophages actively transport nanoparticles in tumors after extravasation","volume":"16","author":"Lin","year":"2022","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.ejpb.2025.114941_b0070","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s11095-008-9629-9","article-title":"Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil","volume":"25","author":"Banciu","year":"2008","journal-title":"Pharm. Res."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2025.114941_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: role of physicochemical properties of particulate carriers\u2013liposomes and microspheres\u2013on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114941_b0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425247.2013.751370","article-title":"Targeted drug delivery to macrophages","volume":"10","author":"Jain","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"19","key":"10.1016\/j.ejpb.2025.114941_b0085","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","article-title":"Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors","volume":"11","author":"Laginha","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114941_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0005-2736(89)90329-5","article-title":"Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studies","volume":"980","author":"Druckmann","year":"1989","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114941_b0095","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature drug release from polyethylene glycol (PEG)-coated liposomal doxorubicin via formation of the membrane attack complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114941_b0100","article-title":"Revealing the incidence of the accelerated blood clearance phenomenon of PEGylated liposomes in individuals using a drug-release reporter liposome","author":"Zheng","year":"2025","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114941_b0105","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1021\/acs.molpharmaceut.5c00024","article-title":"Effect of prodrug activation rate on in vivo drug release and antitumor efficacy of SN38-prodrug-entrapped liposomes","volume":"22","author":"Zhou","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114941_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113762","article-title":"Slow intravenous infusion reduces the accelerated blood clearance of PEGylated liposomes by removing anti-PEG antibodies","volume":"382","author":"Zheng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114941_b0115","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.2147\/IJN.S430877","article-title":"Advancements in macrophage-targeted drug delivery for effective disease management","volume":"18","author":"Liu","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114941_b0120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1039\/D2MH00380E","article-title":"Remote drug loading into liposomes via click reaction","volume":"9","author":"Zheng","year":"2022","journal-title":"Mater. Horiz."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114941_b0125","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1021\/acs.molpharmaceut.3c01140","article-title":"The effect of lipid composition on the liposomal delivery of camptothecin developed by active click loading","volume":"21","author":"Xie","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114941_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125248","article-title":"Effects of linkers on the development of liposomal docetaxel-glutathione prepared by active click loading","volume":"671","author":"Zhou","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114941_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123437","article-title":"A liposomal etoposide with a sustained drug release effectively alleviated the therapy-related leukemia","volume":"646","author":"Xiong","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114941_b0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2017.11.035","article-title":"A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography","volume":"536","author":"Yamamoto","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114941_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020282","article-title":"Towards the development of long circulating phosphatidylserine (PS)- and phosphatidylglycerol (PG)-enriched anti-inflammatory liposomes: is PEGylation effective?","author":"Klein","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114941_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121239","article-title":"Effects of RGD-grafted phosphatidylserine-containing liposomes on the polarization of macrophages and bone tissue regeneration","author":"Wu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114941_b0155","article-title":"Mitigation of radiation-induced esophageal fibrosis by macrophage-targeted phosphatidylserine-containing liposomes with partial PEGylation","author":"Seon","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejpb.2025.114941_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(02)00129-1","article-title":"Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating","author":"Levchenko","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114941_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2018.09.001","article-title":"Drug nanocrystallisation within liposomes","author":"Li","year":"2018","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114941_b0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.cdd.4400404","article-title":"The role of phosphatidylserine in recognition of apoptotic cells by phagocytes","volume":"5","author":"Fadok","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejpb.2025.114941_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114941_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114941_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"7966","key":"10.1016\/j.ejpb.2025.114941_b0190","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","article-title":"Physiology and diseases of tissue-resident macrophages","volume":"618","author":"Lazarov","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114941_b0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2022038827","article-title":"An overview on macrophage targeting: a promising approach","volume":"40","author":"Vemuri","year":"2023","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114941_b0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2025.114941_b0205","doi-asserted-by":"crossref","DOI":"10.1517\/17425247.2011.553218","article-title":"Bone marrow-targeted liposomal carriers","author":"Sou","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114941_b0210","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.123.000955","article-title":"Molecular pathways governing the termination of liver regeneration","author":"de Haan","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejpb.2025.114941_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.07.022","article-title":"Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38","author":"Bala","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114941_b0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2015.12.014","article-title":"Drug delivery to macrophages: Challenges and opportunities","volume":"240","author":"Pei","year":"2016","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114941_b0225","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/17460441.2020.1733525","article-title":"Targeting macrophages: a novel avenue for cancer drug discovery","volume":"15","author":"Kumar","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114941_b0230","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/17425247.4.2.95","article-title":"Liposome-based drug delivery to alveolar macrophages","volume":"4","author":"Vyas","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114941_b0235","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/10717544.2021.1909175","article-title":"Role of macrophage in nanomedicine-based disease treatment","volume":"28","author":"Song","year":"2021","journal-title":"Drug Deliv."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:42:09Z","timestamp":1777592529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0939641125003194"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114941","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing in vivo drug release of macrophage-targeting liposomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114941"}}